×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LFCR – lifecore biomedical, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LFCR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/6
08:00 am
lfcr
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR
Medium
Report
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR
4/4
08:38 am
lfcr
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? [Yahoo! Finance]
Medium
Report
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? [Yahoo! Finance]
3/26
04:39 pm
lfcr
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/26
04:05 pm
lfcr
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3/26
07:00 am
lfcr
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
Medium
Report
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
3/24
03:02 pm
lfcr
Lifecore Biomedical (LFCR) had its "outperform" rating reaffirmed by Barrington Research. They now have a $5.50 price target on the stock.
Low
Report
Lifecore Biomedical (LFCR) had its "outperform" rating reaffirmed by Barrington Research. They now have a $5.50 price target on the stock.
3/23
07:00 am
lfcr
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
Low
Report
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
3/20
05:16 pm
lfcr
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 [Yahoo! Finance]
Low
Report
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/16/2026
08:00 am
lfcr
lifecore biomedical, inc.
MISS
Report
-36.0%
lifecore biomedical, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/2
06:52 pm
lfcr
Form 4 LIFECORE BIOMEDICAL, For: Mar 02 Filed by: Salus Thomas D.
Medium
Report
Form 4 LIFECORE BIOMEDICAL, For: Mar 02 Filed by: Salus Thomas D.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: